We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CRISPR Enhances Cancer Immunotherapy Helping Protect T-Cells Against Friendly Fire

News   Mar 07, 2018 | Original story from Washington University School of Medicine in St. Louis

 
CRISPR Enhances Cancer Immunotherapy Helping Protect T-Cells Against Friendly Fire

Scientists at Washington University School of Medicine in St. Louis now have used the gene-editing technology CRISPR to engineer human T cells that can attack human T cell cancers. They also engineered the T cells to eliminate a potentially dangerous side effect called graft-versus-host disease, where the therapeutic T cells that kill the cancer also attack the patient's organs. John DiPersio, MD, PhD, (right) leads a team developing an "off-the-shelf" CAR-T immunotherapy for hard-to-treat T cell cancers. A new study evaluates the approach in mice with human T cell acute lymphoblastic leukemia. Shown is DiPersio working with co-author Armin Ghobadi, MD, in the lab. Credit: Huy Mach

 
 
 

RELATED ARTICLES

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

Gut Protein Could Prevent Deadly Complication of Bone Marrow Transplant

News

Researchers have discovered that an antimicrobial protein found in the gut can stave off a common and highly lethal side effect of bone marrow transplants.

READ MORE

Drug Blocks Pancreatic Cancer Growth in Mice

News

A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE